tirzepatide vs semaglutide dosage comparison dose Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials Evaluating Dose Titration in Semaglutide

Inject into subcutaneous fat (abdomen or outer thigh), and inject slowly for comfort and improved absorption

Cagrilintide has a long half-life, supporting once-weekly subcutaneous dosing

Other potential contributing factors include dehydration (especially if gastrointestinal symptoms are present) and the body's adaptation period to the medication

Therapeutic Classification and Drug Class Class: GLP-1 receptor agonist Category: Antidiabetic and anti-obesity agent Mechanism-driven therapy targeting incretin pathways Indications in Metabolic and Endocrine Disorders The medication is primarily indicated for conditions characterized by insulin resistance and dysregulated metabolism, including type 2 diabetes and obesity

Sleep patterns and mood may also be affected temporarily